Jean-christophe C. Ianotto
Brest, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications
Use of Ruxolitinib in Pediatric Polycythemia Vera: Expanding Indications Beyond Adult Paradigms? A Case Report.
Journal: Pediatric blood & cancer
Published: July 03, 2026
Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.
Journal: Thrombosis and haemostasis
Published: May 13, 2026
Allele burden expansion in JAK2 V617F and CALR-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment.
Journal: HemaSphere
Published: April 27, 2026
Breaking barriers in rare disease research: a pilot trial of thromboprophylaxis with apixaban versus aspirin in JAK2-Positive myeloproliferative neoplasms.
Journal: Haematologica
Published: April 09, 2026
Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study.
Journal: The Lancet. Haematology
Published: January 30, 2026
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial.
Journal: The Lancet. Haematology
Published: August 18, 2025
Paraneoplastic ocular syndromes: a systematic review of epidemiology, diagnosis and outcomes (2010-2023).
Journal: Journal of ophthalmic inflammation and infection
Published: August 04, 2025
Consequences and impacts of PEG-IFNα2a shortage: first lessons from a MPN French center.
Journal: Annals of hematology
Published: June 24, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.
Journal: American journal of hematology
Published: June 23, 2025
Last Updated: 09/26/2026